Signal peptide of eosinophil cationic protein upregulates transforming growth factor-alpha expression in human cells

Journal of Cellular Biochemistry

Volumn 100, Issue 5, 2007, Pages 1266-1275

  Chang, Hao Teng ^a   Kao, Yu Lin ^a   Wu, Chia Mao ^a,d   Fan, Tan Chi ^a   Lai, Yiu Kay ^a,b   Huang, Kai Ling ^a   Chang, Yuo Sheng ^a   Tsai, Jaw Ji ^c   Chang, Margaret Dah Tsyr ^a  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^b DA YEH UNIVERSITY   (Taiwan)

^c TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^d NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Eosinophil cationic protein; Signal peptide; Signal peptide peptidase; Transforming growth factor alpha

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; EOSINOPHIL CATIONIC PROTEIN; EOSINOPHIL GRANULE PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; PEPTIDE FRAGMENT; SIGNAL PEPTIDASE; SIGNAL PEPTIDE; TRANSFORMING GROWTH FACTOR ALPHA;

AMINO TERMINAL SEQUENCE; ARTICLE; AUTOCRINE EFFECT; CELL CLONE; CELL LINE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; TRANSCRIPTION REGULATION; TRANSLATION REGULATION;

ASPARTIC ENDOPEPTIDASES; CARCINOMA, SQUAMOUS CELL; CULTURE MEDIA, CONDITIONED; ENZYME-LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL CATIONIC PROTEIN; GREEN FLUORESCENT PROTEINS; HL-60 CELLS; HUMANS; PROTEIN SORTING SIGNALS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECOMBINANT FUSION PROTEINS; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR CELLS, CULTURED; UP-REGULATION;

ESCHERICHIA COLI; MAMMALIA; PICHIA PASTORIS;

EID: 33947587217     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21120     Document Type: Article

References (45)

1. Adachi T, Cui CH, Kanda A, Kayaba H, Ohta K, Chihara J. 2004. Activation of epidermal growth factor receptor via CCR3 in bronchial epithelial cells. Biochem Biophys Res Commun 320:292-296.
2. Arteaga CL. 2002. Epidermal growth factor receptor dependence in human tumors: More than just expression? Oncologist 7(Suppl 4):31-39.
3. Awwad R, Humphrey LE, Periyasamy B, Scovell W, Jr, Li W, Coleman K, Lynch M, Carboni J, Brattain MG, Howell GM. 1999. The EGF/TGFalpha response element within the TGFalpha promoter consists of a multi-complex regulatory element. Oncogene 18:5923-5935.
4. Bofill-Cardona E, Kudlacek O, Yang Q, Ahorn H, Freissmuth M, Nanoff C. 2000. Binding of calmodulin to the D2-dopamine receptor reduces receptor signaling by arresting the G protein activation switch. J Biol Chem 275: 32672-32680.
5. Bogsch E, Brink S, Robinson C. 1997. Pathway specificity for a delta pH-dependent precursor thylakoid lumen protein is governed by a 'Sec-avoidance' motif in the transfer peptide and a 'Sec-incompatible' mature protein. EMBO J 16:3851-3859.
6. Booth BW, Adler KB, Bonner JC, Tournier F, Martin LD. 2001. Interleukin-13 induces proliferation of human airway epithelial cells in vitro via a mechanism mediated by transforming growth factor-alpha. Am J Respir Cell Mol Biol 25:739-743.
7. Bousquet J, Jeffery PK, Busse WW, Johnson M, Vignola AM. 2000. Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 161:1720-1745.
8. Fischkoff SA. 1988. Graded increase in probability of eosinophilic differentiation of HL-60 promyelocytic leukemia cells induced by culture under alkaline conditions. Leuk Res 12:679-686.
9. Friedmann E, Lemberg MK, Weihofen A, Dev KK, Dengler U, Rovelli G, Martoglio B. 2004. Consensus analysis of signal peptide peptidase and homologous human aspartic proteases reveals opposite topology of catalytic domains compared with presenilins. J Biol Chem 279:50790-50798.
10. Horiuchi T, Weller PF. 1997. Expression of vascular endothelial growth factor by human eosinophils: Upregulation by granulocyte macrophage colony-stimulating factor and interleukin-5. Am J Respir Cell Mol Biol 17: 70-77.
11. Hoshino M, Takahashi M, Aoike N. 2001. Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis. J Allergy Clin Immunol 107:295-301.
12. Kay AB, Phipps S, Robinson DS. 2004. A role for eosinophils in airway remodelling in asthma. Trends Immunol 25: 477-482.
13. Kim JH, Rho HM. 2002. Activation of the human transforming growth factor alpha (TGF-alpha) gene by the hepatitis B viral X protein (HBx) through AP-2 sites. Mol Cell Biochem 231:155-161.
14. Lemberg MK, Martoglio B. 2002. Requirements for signal peptide peptidase-catalyzed intramembrane proteolysis. Mol Cell 10:735-744.
15. Lemberg MK, Bland FA, Weihofen A, Braud VM, Martoglio B. 2001. Intramembrane proteolysis of signal peptides: An essential step in the generation of HLA-E epitopes. J Immunol 167:6441-6446.
16. Lordan JL, Bucchieri F, Richter A, Konstantinidis A, Holloway JW, Thornber M, Puddicombe SM, Buchanan D, Wilson SJ, Djukanovic R, Holgate ST, Davies DE. 2002. Cooperative effects of Th2 cytokines and allergen on normal and asthmatic bronchial epithelial cells. J Immunol 169:407-414.
17. Madtes DK, Busby HK, Strandjord TP, Clark JG. 1994. Expression of transforming growth factor-alpha and epidermal growth factor receptor is increased following bleomycin-induced lung injury in rats. Am J Respir Cell Mol Biol 11:540-551.
18. Martoglio B. 2003. Intramembrane proteolysis and post-targeting functions of signal peptides. Biochem Soc Trans 31:1243-1247.
19. Martoglio B, Golde TE. 2003. Intramembrane-cleaving aspartic proteases and disease: Presenilins, signal peptide peptidase and their homologs. Hum Mol Genet 12 Spec No 2:R201-R206.
20. Martoglio B, Graf R, Dobberstein B. 1997. Signal peptide fragments of preprolactin and HIV-1 p-gp160 interact with calmodulin. EMBO J 16:6636-6645.
21. McCole DF, Keely SJ, Coffey RJ, Barrett KE. 2002. Transactivation of the epidermal growth factor receptor in colonic epithelial cells by carbachol requires extracellular release of transforming growth factor-alpha. J Biol Chem 277:42603-42612.
22. McLauchlan J, Lemberg MK, Hope G, Martoglio B. 2002. Intramembrane proteolysis promotes trafficking of hepatitis C virus core protein to lipid droplets. EMBO J 21: 3980-3988.
23. Meyer T, Hanson PI, Stryer L, Schulman H. 1992. Calmodulin trapping by calcium-calmodulin-dependent protein kinase. Science 256:1199-1202.
24. Minakami R, Jinnai N, Sugiyama H. 1997. Phosphorylation and calmodulin binding of the metabotropic glutamate receptor subtype 5 (mGluR5) are antagonistic in vitro. J Biol Chem 272:20291-20298.
25. Molet S, Hamid Q, Davoine F, Nutku E, Taha R, Page N, Olivenstein R, Elias J, Chakir J. 2001. IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J Allergy Clin Immunol 108:430-438.
26. Nakajima Y, Yamamoto T, Nakayama T, Nakanishi S. 1999. A relationship between protein kinase C phosphorylation and calmodulin binding to the metabotropic glutamate receptor subtype 7. J Biol Chem 274:27573-27577.
27. Olayioye MA, Neve RM, Lane HA, Hynes NE. 2000. The ErbB signaling network: Receptor heterodimerization in development and cancer. EMBO J 19:3159-3167.
28. Olsson I, Venge P. 1974. Cationic proteins of human granulocytes. II. Separation of the cationic proteins of the granules of leukemic myeloid cells. Blood 44:235-246.
29. Ono M, Morisawa K, Nie J, Ota K, Taniguchi T, Saibara T, Onishi S. 1998. Transactivation of transforming growth factor alpha gene by hepatitis B virus preS1. Cancer Res 58:1813-1816.
30. Peterson CG, Jornvall H, Venge P. 1988. Purification and characterization of eosinophil cationic protein from normal human eosinophils. Eur J Haematol 40:415-423.
31. Piepkorn M, Pittelkow MR, Cook PW. 1998. Autocrine regulation of keratinocytes: The emerging role of heparin-binding, epidermal growth factor-related growth factors. J Invest Dermatol 111:715-721.
32. Rosenberg HF. 1995. Recombinant human eosinophil cationic protein. Ribonuclease activity is not essential for cytotoxicity. J Biol Chem 270:7876-7881.
33. Rosenberg HF, Ackerman SJ, Tenen DG. 1989. Human eosinophil cationic protein. Molecular cloning of a cytotoxin and helminthotoxin with ribonuclease activity. J Exp Med 170:163-176.
34. Rusch V, Klimstra D, Venkatraman E, Pisters PW, Langenfeld J, Dmitrovsky E. 1997. Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor alpha is frequent in resectable non-small cell lung cancer but does not predict tumor progression. Clin Cancer Res 3:515-522.
35. Schmid-Grendelmeier P, Altznauer F, Fischer B, Bizer C, Straumann A, Menz G, Blaser K, Wuthrich B, Simon HU. 2002. Eosinophils express functional IL-13 in eosinophilic inflammatory diseases. J Immunol 169:1021-1027.
36. Tiffany HL, Li F, Rosenberg HF. 1995. Hyperglycosylation of eosinophil ribonucleases in a promyelocytic leukemia cell line and in differentiated peripheral blood progenitor cells. J Leukoc Biol 58:49-54.
37. Tsao MS, Zhu H, Viallet J. 1996. Autocrine growth loop of the epidermal growth factor receptor in normal and immortalized human bronchial epithelial cells. Exp Cell Res 223:268-273.
38. Vyhlidal C, Samudio I, Kladde MP, Safe S. 2000. Transcriptional activation of transforming growth factor alpha by estradiol: Requirement for both a GC-rich site and an estrogen response element half-site. J Mol Endocrinol 24:329-338.
39. Wang D, Sadee W, Quillan JM. 1999. Calmodulin binding to G protein-coupling domain of opioid receptors. J Biol Chem 274:22081-22088.
40. Weihofen A, Binns K, Lemberg MK, Ashman K, Martoglio B. 2002. Identification of signal peptide peptidase, a presenilin-type aspartic protease. Science 296:2215-2218.
41. Wong DT, Weller PF, Galli SJ, Elovic A, Rand TH, Gallagher GT, Chiang T, Chou MY, Matossian K, McBride J. 1990. Human eosinophils express transforming growth factor alpha. J Exp Med 172:673-681.
42. Wong DT, Elovic A, Matossian K, Nagura N, McBride J, Chou MY, Gordon JR, Rand TH, Galli SJ, Weller PF. 1991. Eosinophils from patients with blood eosinophilia express transforming growth factor beta 1. Blood 78: 2702-2707.
43. Wu CM, Chang MD. 2004. Signal peptide of eosinophil cationic protein is toxic to cells lacking signal peptide peptidase. Biochem Biophys Res Commun 322:585-592.
44. Yarden Y, Sliwkowski MX. 2001. Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2:127-137.
45. Ye J, Dave UP, Grishin NV, Goldstein JL, Brown MS. 2000. Asparagine-proline sequence within membrane-spanning segment of SREBP triggers intramembrane cleavage by site-2 protease. Proc Natl Acad Sci USA 97:5123-5128.